Atazanavir

Generic name: Pronounced as (at a za na' veer)
Brand names
  • Reyataz®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 01/15/2022

Atazanavir is used along with other medications to treat human immunodeficiency virus (HIV) infection in adults and children who are at least 3 months of age and weigh at least 22 lb (10 kg). Atazanavir is in a class of medications called protease inhibitors. It works by decreasing the amount of HIV in the blood. Although atazanavir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Atazanavir must be given with other medications that treat HIV infection to completely treat the infection. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting the HIV virus to other people.

Atazanavir comes as a capsule and as a powder to take by mouth. Atazanavir capsules are taken with food once a day and may be given with a pharmacokinetic booster (medication given to increase the levels of another drug in the body) such as ritonavir or cobicistat. Atazanavir powder must be taken with food and ritonavir. Take atazanavir at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take atazanavir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

You will take other medications for HIV while you are taking atazanavir. Your doctor will tell you whether these medications should be taken at the same time as atazanavir, or several hours before or after you take atazanavir. Follow this schedule carefully, and ask your doctor or pharmacist if you have questions about the times you should take your medications.

Swallow the capsules whole; do not split, chew, or open them. If you are unable to swallow the capsules, tell your doctor or pharmacist.

Atazanavir powder may be added to foods such as applesauce or yogurt, or liquids such as water, milk, or infant formula. Mix well, and take all of the mixture right away in order to take the full dose. If mixed with water, eat a snack or meal right away after taking the powder mixture. For infants (older than 3 months of age) unable to drink from a cup, the powder can be mixed with infant formula and given with an oral dosing syringe; do not give the mixture to the infant in a baby bottle. If the mixture is not taken immediately it must be stored at room temperature and taken within 1 hour. Carefully read the manufacturer's instructions that describe how to mix and take a dose of atazanavir. Be sure to ask your pharmacist or doctor if you have any questions about how to mix or take this medication.

Talk to the doctor about what to do if your baby vomits, spits up, or only takes part of the dose of atazanavir.

Atazanavir controls HIV but does not cure it. Atazanavir does not treat HIV infection alone and must always be given with a complete regimen. It is important that all of the medications prescribed by your doctor to treat HIV infection are taken together so that the medications will continue to work to control the infection. Continue to take atazanavir even if you feel well. Do not stop taking atazanavir without talking to your doctor. When your supply of atazanavir starts to run low, get more from your doctor or pharmacist. If you stop taking atazanavir or skip doses, your condition may become more difficult to treat.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient. Read this information carefully and ask your doctor or pharmacist if you have any questions.

Atazanavir is also sometimes used to prevent infection in healthcare workers or other people who were accidentally exposed to HIV. Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking atazanavir,

  • tell your doctor and pharmacist if you are allergic to atazanavir, any other medications, or any of the ingredients in atazanavir capsules or powder. Your doctor may tell you not to take atazanavir. Ask your pharmacist for a list of the ingredients.

  • tell your doctor if you are taking any of following medications or herbal products: alfuzosin (Uroxatral); cisapride (Propulsid; not available in the US); elbasvir and grazoprevir (Zepatier); ergot alkaloids such as dihydroergotamine (D.H.E. 45, Migranal), ergonovine, ergotamine (Ergomar, in Cafergot, in Migergot), or methylergonovine (Methergine); glecaprevir and pibrentasvir (Mavyret); indinavir (Crixivan); irinotecan (Camptosar); lovastatin (Altoprev); lurasidone (Latuda); midazolam by mouth; nevirapine (Viramune), pimozide (Orap); rifampin (Rimactane, Rifadin, in Rifater, in Rifamate); sildenafil (only Revatio brand used for lung disease); simvastatin (Zocor, in Vytorin); St. John's wort; and triazolam (Halcion). Your doctor will probably tell you not to take atazanavir if you are taking one or more of these medications.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, herbal products, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); antidepressants ('mood elevators') such as amitriptyline, desipramine (Norpramin), doxepin (Silenor, Zonalon), imipramine (Tofranil, Surmontil), protriptyline (Vivactil), trazodone, and trimipramine (Surmontil); certain antifungals such as itraconazole (Onmel, Sporanox), ketoconazole (Extina, Nizoral, Xolegel), and voriconazole (Vfend); bepridil (Vascor) (not available in the US); beta blockers such as labetalol (Trandate), nadolol (Corgard, in Corzide), and propranolol (Hemangeol, Inderal, Innopran XL, in Inderide); boceprevir (no longer available in the U.S.; Victrelis); bosentan (Tracleer); buprenorphine (Buprenex, Butrans, in Bunavail, in Suboxone, in Zubsolv); calcium channel blockers such as diltiazem (Cardizem, Cartia, Tiazac, others), felodipine, nicardipine (Cardene), nifedipine (Adalat, Afeditab, Procardia), and verapamil (Calan, Verelan, in Tarka, others); certain cholesterol-lowering medications (statins) such as atorvastatin (Lipitor, in Caduet), and rosuvastatin (Crestor); clarithromycin (Biaxin, in Prevpac); colchicine (Colcrys, Mitigare); digoxin (Lanoxin); fluticasone (Flonase, Flovent, in Advair); medications for irregular heartbeat such as amiodarone (Cordarone, Nexterone, Pacerone), lidocaine (Octocaine, Xylocaine), and quinidine (in Nuedexta); medications that suppress the immune system such as cyclosporine (Gengraf, Neoral, Sandimmune), sirolimus (Rapamune), and tacrolimus (Astagraf, Prograf); other medications for HIV or AIDS including efavirenz (Sustiva, in Atripla), ritonavir (Norvir, in Kaletra, in Viekira Pak), saquinavir (Invirase), and tenofovir (Viread, in Atripla, in Stribild, in Truvada, others); midazolam by injection; paclitaxel (Abraxane, Taxol); certain phosphodiesterase inhibitors (PDE-5 inhibitors) used for erectile dysfunction such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra, Staxyn); repaglinide (Prandin, in Prandimet); quetiapine (Seroquel); rifabutin (Mycobutin); salmeterol (Serevent, in Advair); sofosbuvir, velpatasvir, and voxilaprevir (Sovaldi, Epclusa, Vosevi); and tadalafil (Adcirca, Cialis). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with atazanavir, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • if you are taking antacids, didanosine delayed-release capsules (Videx EC), or any other buffered medication such as buffered aspirin (Bufferin), take atazanavir 2 hours before or 1 hour after you take the medication. Ask your doctor or pharmacist if you are not sure if any of the medications you are taking are buffered.

  • tell your doctor if you are taking a medication for indigestion, heartburn, or ulcers such as cimetidine, esomeprazole (Nexium, in Vimovo), famotidine (Pepcid, in Duexis), lansoprazole (Prevacid, in Prevpac), nizatidine (Axid), omeprazole (Prilosec, in Zegerid), pantoprazole (Protonix), rabeprazole (AcipHex), or ranitidine (Zantac). Your doctor may tell you not to take the medication or to take a lower dose of the medication. If you are to continue taking the medication, your doctor will tell you how much time you should allow between taking the medication and taking atazanavir.

  • tell your doctor if you have or have ever had an irregular heartbeat, diabetes or high blood sugar, hemophilia (a condition in which the blood does not clot normally) or any other bleeding disorder, hepatitis (a viral infection of the liver) or any other liver disease, kidney or heart disease.

  • tell your doctor if you are pregnant or plan to become pregnant. If you become pregnant while taking atazanavir, call your doctor. You should not breast-feed if you are infected with HIV and are taking atazanavir.

  • you should know that atazanavir may decrease the effectiveness of hormonal contraceptives (birth control pills, patches, rings, implants, and injections). Talk to your doctor about methods of birth control that will work for you while you are taking atazanavir.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking atazanavir.

  • you should know that you may experience hyperglycemia (increases in your blood sugar) while you are taking this medication, even if you do not already have diabetes. Tell your doctor immediately if you have any of the following symptoms while you are taking atazanavir: extreme thirst, frequent urination, extreme hunger, blurred vision, or weakness. It is very important to call your doctor as soon as you have any of these symptoms, because high blood sugar that is not treated can cause a serious condition called ketoacidosis. Ketoacidosis may become life-threatening if it is not treated at an early stage. Symptoms of ketoacidosis include: dry mouth, nausea and vomiting, shortness of breath, breath that smells fruity, and decreased consciousness.

  • you should know that while you are taking atazanavir your body fat may increase or move to different areas of your body such as the back of your neck and upper shoulders ('buffalo hump'), stomach, and breasts. You may lose fat from your arms, legs, face, and buttocks. Talk to your doctor if you notice any of these changes in your body fat.

  • if you have phenylketonuria (PKU, an inherited condition in which a special diet must be followed to prevent damage to your brain that can cause severe intellectual disability), you should know that atazanavir oral powder is sweetened with aspartame that forms phenylalanine.

  • you should know that while you are taking medications to treat HIV infection, your immune system may get stronger and begin to fight other infections that were already in your body. This may cause you to develop symptoms of those infections. If you have new or worsening symptoms at anytime during your treatment with atazanavir, be sure to tell your doctor.

Talk to your doctor about eating grapefruit or drinking grapefruit juice while taking this medicine.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Atazanavir may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • stomach pain

    • diarrhea

    • headache

    • depression

    • fever

    • difficulty falling asleep or staying asleep

    • muscle pain

    • mild rash

    • numbness, burning, pain, or tingling of hands or feet

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment:

    • irregular heartbeat

    • dizziness

    • feeling faint or lightheadedness

    • vision changes

    • yellowing of skin or eyes (especially in newborn infants)

    • pain in your back or side

    • pain or burning with urination

    • blood in urine

    • vomiting

    • loss of appetite

    • swelling of hands, feet, legs, or ankles

    • decreased urination

    • dark-colored urine

    • light-colored bowel movements

    • erection that lasts longer than 4 hours

  • If you develop a severe rash with any of the following symptoms, stop taking atazanavir and call your doctor immediately or get emergency medical treatment:

    • general ill feeling or 'flu-like' symptoms

    • fever

    • muscle or joint aches

    • red or swollen eyes

    • blisters or peeling skin

    • mouth sores

    • swelling of your face or neck

    • painful, warm, or red lump under your skin

  • Atazanavir may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container or packet it came in, tightly closed, and out of reach of children and pets. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • yellowing of skin or eyes

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests before and during your treatment to check your body's response to atazanavir.

Keep a supply of atazanavir on hand. Do not wait until you run out of medication to refill your prescription.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Moxifloxacin.
Repaglinide Repaglinide Atazanavir may decrease the excretion rate of Repaglinide which could result in a higher serum level.
Montelukast Montelukast The metabolism of Atazanavir can be decreased when combined with Montelukast.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Atazanavir.
Leflunomide Leflunomide The metabolism of Atazanavir can be decreased when combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Atazanavir can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Atazanavir can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The serum concentration of Atorvastatin can be increased when it is combined with Atazanavir.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Dolasetron.
Alendronate Alendronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Atazanavir is combined with Alendronic acid.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Atazanavir.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Anagrelide.
Calcium Carbonate Calcium Carbonate Calcium carbonate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candesartan Candesartan The metabolism of Candesartan can be decreased when combined with Atazanavir.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Atazanavir.
Clopidogrel Clopidogrel The metabolism of Atazanavir can be decreased when combined with Clopidogrel.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole Atazanavir may decrease the excretion rate of Erythromycin which could result in a higher serum level.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Atazanavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Atazanavir.
Guanfacine Guanfacine The metabolism of Guanfacine can be decreased when combined with Atazanavir.
Magnesium Hydroxide Magnesium Hydroxide Magnesium hydroxide can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide Magnesium Oxide Magnesium oxide can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylergonovine Methylergonovine The metabolism of Atazanavir can be decreased when combined with Methylergometrine.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be decreased when used in combination with Atazanavir.
Mycophenolate Mycophenolate The metabolism of Mycophenolic acid can be decreased when combined with Atazanavir.
Olsalazine Olsalazine The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Olsalazine.
Paregoric Paregoric The metabolism of Morphine can be decreased when combined with Atazanavir.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Acebutolol.
Potassium Potassium Atazanavir may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone The metabolism of Atazanavir can be decreased when combined with Prednisone.
Ranitidine Ranitidine Ranitidine can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Reserpine Reserpine Reserpine may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Rizatriptan Rizatriptan Atazanavir may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Atazanavir may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Atazanavir.
Tiludronate Tiludronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Atazanavir is combined with Etidronic acid.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Atazanavir.
Triamcinolone Triamcinolone The metabolism of Atazanavir can be decreased when combined with Triamcinolone.
Ampicillin Injection Ampicillin Injection Atazanavir may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection The metabolism of Atazanavir can be decreased when combined with Doxycycline.
Famotidine Injection Famotidine Injection Famotidine can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluconazole Injection Fluconazole Injection The metabolism of Atazanavir can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection Atazanavir may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Atazanavir.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Atazanavir can be decreased when combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection Atazanavir may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Atazanavir.
Morphine Injection Morphine Injection The metabolism of Morphine can be decreased when combined with Atazanavir.
Pamidronate Injection Pamidronate Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Atazanavir is combined with Pamidronic acid.
Vancomycin Injection Vancomycin Injection Atazanavir may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be decreased when combined with Atazanavir.
Altretamine Altretamine Atazanavir may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Cefuroxime Cefuroxime The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefuroxime.
Cyclosporine Cyclosporine The metabolism of Atazanavir can be decreased when combined with Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Atazanavir.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Granisetron.
Torsemide Torsemide The metabolism of Atazanavir can be decreased when combined with Torasemide.
Olanzapine Olanzapine Olanzapine can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alosetron Alosetron The metabolism of Atazanavir can be decreased when combined with Alosetron.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Atazanavir.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Hydroxychloroquine.
Meloxicam Meloxicam The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Atazanavir.
Orlistat Orlistat The metabolism of Atazanavir can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Atazanavir can be increased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole The therapeutic efficacy of Atazanavir can be decreased when used in combination with Pantoprazole.
Risedronate Risedronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Atazanavir is combined with Risedronic acid.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Temozolomide Temozolomide Atazanavir may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Atazanavir may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra Anakinra The metabolism of Atazanavir can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Desloratadine.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Atazanavir.
Etanercept Injection Etanercept Injection The metabolism of Atazanavir can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Modafinil can be decreased when combined with Atazanavir.
Perindopril Perindopril Atazanavir may decrease the excretion rate of Perindopril which could result in a higher serum level.
Tenofovir Tenofovir The serum concentration of Atazanavir can be decreased when it is combined with Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Choline magnesium trisalicylate.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Atazanavir.
Epinephrine Injection Epinephrine Injection The metabolism of Atazanavir can be decreased when combined with Epinephrine.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Atazanavir.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Escitalopram.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Zonisamide Zonisamide Atazanavir may decrease the excretion rate of Zonisamide which could result in a higher serum level.
Adalimumab Injection Adalimumab Injection The metabolism of Atazanavir can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Atazanavir.
Atomoxetine Atomoxetine Atazanavir may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Ezetimibe Ezetimibe The metabolism of Ezetimibe can be decreased when combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Atazanavir.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Atazanavir.
Mefloquine Mefloquine The metabolism of Atazanavir can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The serum concentration of Rosuvastatin can be increased when it is combined with Atazanavir.
Vardenafil Vardenafil The serum concentration of Vardenafil can be increased when it is combined with Atazanavir.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Atazanavir.
Aprepitant Aprepitant The metabolism of Atazanavir can be decreased when combined with Aprepitant.
Emtricitabine Emtricitabine Atazanavir may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Atazanavir may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil The serum concentration of Tadalafil can be increased when it is combined with Atazanavir.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Atazanavir can be increased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Atazanavir.
Infliximab Injection Infliximab Injection The metabolism of Atazanavir can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Atazanavir can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Atazanavir.
Rifaximin Rifaximin The metabolism of Atazanavir can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Atazanavir.
Norethindrone Norethindrone The serum concentration of Norethisterone can be increased when it is combined with Atazanavir.
Tinidazole Tinidazole Atazanavir may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The serum concentration of Atazanavir can be decreased when it is combined with Bosentan.
Cefditoren Cefditoren Atazanavir may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Atazanavir may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Atazanavir.
Eszopiclone Eszopiclone The serum concentration of Eszopiclone can be increased when it is combined with Atazanavir.
Ganciclovir Ganciclovir Atazanavir may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Atazanavir.
Ribavirin Ribavirin Atazanavir may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Solifenacin.
Valganciclovir Valganciclovir Atazanavir may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The serum concentration of Voriconazole can be increased when it is combined with Atazanavir.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Atazanavir is combined with Zoledronic acid.
Adefovir Adefovir The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Adefovir.
Dextroamphetamine Dextroamphetamine Atazanavir may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Atazanavir can be increased when combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be decreased when used in combination with Atazanavir.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be decreased when used in combination with Atazanavir.
Ibandronate Ibandronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Atazanavir is combined with Ibandronate.
Ramelteon Ramelteon Atazanavir may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Atazanavir.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Atazanavir.
Deferasirox Deferasirox The metabolism of Deferasirox can be decreased when combined with Atazanavir.
Tipranavir Tipranavir The metabolism of Atazanavir can be decreased when combined with Tipranavir.
Felbamate Felbamate The metabolism of Atazanavir can be increased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Atazanavir.
Ranolazine Ranolazine The metabolism of Atazanavir can be decreased when combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Atazanavir can be increased when combined with Abatacept.
Rasagiline Rasagiline Atazanavir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Imatinib Imatinib The metabolism of Atazanavir can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Atazanavir.
Varenicline Varenicline Atazanavir may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The metabolism of Atazanavir can be decreased when combined with Gefitinib.
Albuterol Albuterol Atazanavir may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Atazanavir can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Atazanavir may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Atazanavir.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The therapeutic efficacy of Varicella Zoster Vaccine (Live/attenuated) can be decreased when used in combination with Atazanavir.
Fulvestrant Injection Fulvestrant Injection The metabolism of Fulvestrant can be decreased when combined with Atazanavir.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Atazanavir.
Lubiprostone Lubiprostone Atazanavir may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Oxaliplatin.
Posaconazole Posaconazole The metabolism of Posaconazole can be decreased when combined with Atazanavir.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Primaquine.
Darunavir Darunavir The metabolism of Atazanavir can be decreased when combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection Atazanavir may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Dimenhydrinate.
Nabilone Nabilone The metabolism of Atazanavir can be decreased when combined with Nabilone.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Atazanavir.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Atazanavir can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Atazanavir can be decreased when combined with Sunitinib.
Dronabinol Dronabinol The metabolism of Dronabinol can be decreased when combined with Atazanavir.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Atazanavir.
Levocetirizine Levocetirizine Atazanavir may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Atazanavir may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Atazanavir.
Armodafinil Armodafinil The metabolism of Atazanavir can be decreased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Atazanavir may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Ivermectin Ivermectin The metabolism of Atazanavir can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Atazanavir.
Maraviroc Maraviroc The metabolism of Maraviroc can be decreased when combined with Atazanavir.
Lenalidomide Lenalidomide Atazanavir may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Atazanavir.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Toremifene.
Raltegravir Raltegravir The metabolism of Raltegravir can be decreased when combined with Atazanavir.
Bexarotene Bexarotene The metabolism of Bexarotene can be increased when combined with Atazanavir.
Budesonide Budesonide The metabolism of Atazanavir can be decreased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Atazanavir can be decreased when combined with Chloramphenicol.
Desmopressin Desmopressin Atazanavir may decrease the excretion rate of Desmopressin which could result in a higher serum level.
Doripenem Injection Doripenem Injection Atazanavir may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The serum concentration of Etravirine can be increased when it is combined with Atazanavir.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Atazanavir can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Desvenlafaxine can be decreased when combined with Atazanavir.
Cevimeline Cevimeline Atazanavir may decrease the excretion rate of Cevimeline which could result in a higher serum level.
Tretinoin Tretinoin The metabolism of Atazanavir can be decreased when combined with Tretinoin.
Pilocarpine Pilocarpine The metabolism of Atazanavir can be decreased when combined with Pilocarpine.
Flecainide Flecainide The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Atazanavir can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Atazanavir.
Irinotecan Injection Irinotecan Injection The serum concentration of SN-38, an active metabolite of Irinotecan, can be increased when used in combination with Atazanavir.
Daptomycin Injection Daptomycin Injection Atazanavir may decrease the excretion rate of Daptomycin which could result in a higher serum level.
Mitotane Mitotane The metabolism of Atazanavir can be increased when combined with Mitotane.
Methylnaltrexone Injection Methylnaltrexone Injection Atazanavir may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Atazanavir.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Atazanavir.
Naltrexone Injection Naltrexone Injection The metabolism of Naltrexone can be decreased when combined with Atazanavir.
Dexrazoxane Injection Dexrazoxane Injection Atazanavir may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Atazanavir.
Milnacipran Milnacipran The metabolism of Milnacipran can be decreased when combined with Atazanavir.
Dexlansoprazole Dexlansoprazole Atazanavir can cause a decrease in the absorption of Dexlansoprazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Plerixafor Injection Plerixafor Injection Atazanavir may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Atazanavir.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Degarelix.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Betaxolol.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Atazanavir.
Prasugrel Prasugrel Atazanavir may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Atazanavir.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Atazanavir.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Atazanavir.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Atazanavir.
Pralatrexate Injection Pralatrexate Injection Atazanavir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Atazanavir may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Atazanavir.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Atazanavir.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Atazanavir.
Topotecan Topotecan The metabolism of Atazanavir can be increased when combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Atazanavir can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Atazanavir can be decreased when combined with Pazopanib.
Asenapine Asenapine Asenapine can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pitavastatin Pitavastatin The serum concentration of Pitavastatin can be increased when it is combined with Atazanavir.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Atazanavir.
Levonorgestrel Levonorgestrel The serum concentration of Levonorgestrel can be increased when it is combined with Atazanavir.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be decreased when used in combination with Atazanavir.
Tocilizumab Injection Tocilizumab Injection The metabolism of Atazanavir can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Atazanavir may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Atazanavir.
Ceftaroline Injection Ceftaroline Injection The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Ceftaroline fosamil.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Atazanavir can be increased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Atazanavir.
Ipilimumab Injection Ipilimumab Injection Atazanavir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Atazanavir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Atazanavir may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Atazanavir.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Atazanavir.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Atazanavir.
Rilpivirine Rilpivirine The serum concentration of Rilpivirine can be increased when it is combined with Atazanavir.
Telaprevir Telaprevir The excretion of Glecaprevir can be decreased when combined with Atazanavir.
Cyclophosphamide Injection Cyclophosphamide Injection The serum concentration of the active metabolites of Cyclophosphamide can be increased when Cyclophosphamide is used in combination with Atazanavir.
Abiraterone Abiraterone The metabolism of Atazanavir can be decreased when combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Triptorelin.
Rivaroxaban Rivaroxaban Atazanavir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ticagrelor Ticagrelor The metabolism of Atazanavir can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Atazanavir can be decreased when combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Atazanavir.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Atazanavir.
Clobazam Clobazam The metabolism of Atazanavir can be increased when combined with Clobazam.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Atazanavir.
Vismodegib Vismodegib The metabolism of Vismodegib can be decreased when combined with Atazanavir.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Atazanavir.
Deferiprone Deferiprone Atazanavir may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Atazanavir.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Atazanavir.
Cabergoline Cabergoline The metabolism of Atazanavir can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Atazanavir can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The excretion of Ambrisentan can be decreased when combined with Atazanavir.
Fondaparinux Injection Fondaparinux Injection Atazanavir may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
Ezogabine Ezogabine The metabolism of Tiagabine can be decreased when combined with Atazanavir.
Enzalutamide Enzalutamide The metabolism of Atazanavir can be increased when combined with Enzalutamide.
Mirabegron Mirabegron Atazanavir may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib Regorafenib The metabolism of Atazanavir can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Atazanavir can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Atazanavir can be decreased when combined with Corticotropin.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be decreased when used in combination with Atazanavir.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Atazanavir.
Teduglutide Injection Teduglutide Injection Atazanavir may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline Bedaquiline The metabolism of Bedaquiline can be decreased when combined with Atazanavir.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Atazanavir.
Alogliptin Alogliptin Atazanavir may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Atazanavir.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Atazanavir.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Atazanavir.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Atazanavir.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Atazanavir.
Dabrafenib Dabrafenib The metabolism of Atazanavir can be decreased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Atazanavir.
Trametinib Trametinib Atazanavir may decrease the excretion rate of Trametinib which could result in a higher serum level.
Dolutegravir Dolutegravir The serum concentration of Dolutegravir can be increased when it is combined with Atazanavir.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Atazanavir.
Ertapenem Injection Ertapenem Injection Atazanavir may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Atazanavir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Perampanel Perampanel The metabolism of Atazanavir can be increased when combined with Perampanel.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Atazanavir.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Atazanavir.
Ketorolac Injection Ketorolac Injection The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Atazanavir.
Simeprevir Simeprevir Atazanavir may decrease the excretion rate of Simeprevir which could result in a higher serum level.
Sofosbuvir Sofosbuvir Atazanavir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Atazanavir.
Apremilast Apremilast The metabolism of Atazanavir can be increased when combined with Apremilast.
Droxidopa Droxidopa Atazanavir may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Atazanavir.
Siltuximab Injection Siltuximab Injection The metabolism of Atazanavir can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be decreased when used in combination with Atazanavir.
Eslicarbazepine Eslicarbazepine The metabolism of Eslicarbazepine can be decreased when combined with Atazanavir.
Belinostat Injection Belinostat Injection The metabolism of Belinostat can be decreased when combined with Atazanavir.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Atazanavir.
Testosterone Injection Testosterone Injection The metabolism of Atazanavir can be increased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Atazanavir can be increased when combined with Oritavancin.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Atazanavir.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Atazanavir.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Atazanavir.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Atazanavir.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Atazanavir.
Edoxaban Edoxaban Atazanavir may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Atazanavir.
Caspofungin Injection Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Atazanavir.
Methamphetamine Methamphetamine Atazanavir may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Atazanavir.
Riociguat Riociguat The serum concentration of Riociguat can be increased when it is combined with Atazanavir.
Lanreotide Injection Lanreotide Injection The metabolism of Atazanavir can be decreased when combined with Lanreotide.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Atazanavir.
Secukinumab Injection Secukinumab Injection The metabolism of Atazanavir can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Atazanavir.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Atazanavir.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be decreased when used in combination with Atazanavir.
Lenvatinib Lenvatinib The metabolism of Atazanavir can be increased when combined with Lenvatinib.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Atazanavir.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Haloperidol.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Atazanavir which could result in a lower serum level and potentially a reduction in efficacy.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Ivabradine.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Isavuconazonium can be increased when it is combined with Atazanavir.
Macitentan Macitentan Atazanavir may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Atazanavir.
Flibanserin Flibanserin The metabolism of Flibanserin can be decreased when combined with Atazanavir.
Prednisolone Prednisolone The metabolism of Atazanavir can be decreased when combined with Prednisolone.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Atazanavir.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Atazanavir.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Ziprasidone.
Penicillin G Procaine Injection Penicillin G Procaine Injection Atazanavir may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Atazanavir.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Atazanavir.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Atazanavir.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Atazanavir.
Osimertinib Osimertinib The metabolism of Osimertinib can be decreased when combined with Atazanavir.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Atazanavir.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Atazanavir.
Rifapentine Rifapentine The metabolism of Atazanavir can be increased when combined with Rifapentine.
Lesinurad Lesinurad Atazanavir may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Atazanavir.
Dexamethasone Injection Dexamethasone Injection The metabolism of Atazanavir can be decreased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection Atazanavir may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax Venetoclax The metabolism of Atazanavir can be decreased when combined with Venetoclax.
Selexipag Selexipag The excretion of Selexipag can be decreased when combined with Atazanavir.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection The metabolism of Furosemide can be decreased when combined with Atazanavir.
Rucaparib Rucaparib The metabolism of Atazanavir can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Atazanavir.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Atazanavir.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Atazanavir.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Deutetrabenazine.
Valbenazine Valbenazine Atazanavir may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The serum concentration of Deflazacort can be increased when it is combined with Atazanavir.
Safinamide Safinamide The metabolism of Atazanavir can be decreased when combined with Safinamide.
Naldemedine Naldemedine Atazanavir may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The metabolism of Atazanavir can be increased when combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Atazanavir can be decreased when combined with Midostaurin.
Neratinib Neratinib The serum concentration of Neratinib can be increased when it is combined with Atazanavir.
Enasidenib Enasidenib The metabolism of Atazanavir can be decreased when combined with Enasidenib.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Atazanavir can be decreased when combined with Fosaprepitant.
Benznidazole Benznidazole Atazanavir may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Atazanavir.
Delafloxacin Delafloxacin The metabolism of Delafloxacin can be decreased when combined with Atazanavir.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Atazanavir.
Acalabrutinib Acalabrutinib The metabolism of Atazanavir can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Atazanavir.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be decreased when used in combination with Atazanavir.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Atazanavir.
Buprenorphine Injection Buprenorphine Injection The metabolism of Atazanavir can be decreased when combined with Buprenorphine.
Apalutamide Apalutamide The metabolism of Atazanavir can be decreased when combined with Apalutamide.
Penicillamine Penicillamine The excretion of Penicillamine can be decreased when combined with Atazanavir.
Fostamatinib Fostamatinib The metabolism of Atazanavir can be decreased when combined with Fostamatinib.
Avatrombopag Avatrombopag The metabolism of Atazanavir can be increased when combined with Avatrombopag.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Atazanavir.
Sodium Zirconium Cyclosilicate Sodium Zirconium Cyclosilicate Sodium zirconium cyclosilicate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lofexidine Lofexidine Atazanavir may decrease the excretion rate of Lofexidine which could result in a higher serum level.
Plazomicin Injection Plazomicin Injection Atazanavir may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Atazanavir.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Encorafenib.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Atazanavir.
Ivosidenib Ivosidenib The metabolism of Atazanavir can be decreased when combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Atazanavir.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Atazanavir.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Atazanavir.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Atazanavir.
Stiripentol Stiripentol The metabolism of Atazanavir can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Atazanavir.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Atazanavir.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Atazanavir can be decreased when combined with Paclitaxel.
Rifamycin Rifamycin The metabolism of Atazanavir can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Atazanavir.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Atazanavir can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Atazanavir is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic Atazanavir may decrease the excretion rate of Acyclovir which could result in a higher serum level.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Atazanavir.
Esomeprazole Injection Esomeprazole Injection Atazanavir can cause a decrease in the absorption of Esomeprazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alpelisib Alpelisib The serum concentration of Atazanavir can be decreased when it is combined with Alpelisib.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection The risk or severity of adverse effects can be increased when Atazanavir is combined with Polatuzumab vedotin.
Solriamfetol Solriamfetol Atazanavir may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Darolutamide Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Atazanavir.
Triclabendazole Triclabendazole The metabolism of Atazanavir can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Atazanavir.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Atazanavir.
Upadacitinib Upadacitinib The metabolism of Upadacitinib can be decreased when combined with Atazanavir.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Atazanavir.
Pitolisant Pitolisant The serum concentration of Atazanavir can be decreased when it is combined with Pitolisant.
Pretomanid Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Atazanavir.
Lefamulin Lefamulin Atazanavir may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The metabolism of Atazanavir can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Atazanavir can be increased when combined with Fosphenytoin.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Atazanavir.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Atazanavir.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Atazanavir.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Atazanavir.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Atazanavir.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Atazanavir.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Atazanavir.
Bempedoic Acid Bempedoic Acid The excretion of Bempedoic acid can be decreased when combined with Atazanavir.
Cenobamate Cenobamate The serum concentration of Atazanavir can be decreased when it is combined with Cenobamate.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Atazanavir.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Atazanavir.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Atazanavir.
Rimegepant Rimegepant The metabolism of Rimegepant can be decreased when combined with Atazanavir.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Atazanavir.
Remdesivir Injection Remdesivir Injection The excretion of Remdesivir can be decreased when combined with Atazanavir.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection The serum concentration of Sacituzumab govitecan can be increased when it is combined with Atazanavir.
Ripretinib Ripretinib The serum concentration of Ripretinib can be increased when it is combined with Atazanavir.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be increased when it is combined with Atazanavir.
Capmatinib Capmatinib The serum concentration of Capmatinib can be increased when it is combined with Atazanavir.
Lemborexant Lemborexant The serum concentration of Lemborexant can be increased when it is combined with Atazanavir.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Atazanavir.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Atazanavir.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Atazanavir may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib The serum concentration of Atazanavir can be increased when it is combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Atazanavir can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Relugolix.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The serum concentration of Drospirenone can be increased when it is combined with Atazanavir.
Viloxazine Viloxazine Atazanavir may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Atazanavir can be increased when combined with Vitamin E.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Atazanavir.
Fenoprofen Fenoprofen The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Atazanavir.
Indomethacin Indomethacin The metabolism of Indomethacin can be decreased when combined with Atazanavir.
Mefenamic Acid Mefenamic Acid The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Atazanavir.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Atazanavir.
Tolmetin Tolmetin The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Atazanavir.
Sulindac Sulindac The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Atazanavir.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Atazanavir.
Isotretinoin Isotretinoin Atazanavir may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Atazanavir may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Sodium Bicarbonate Sodium Bicarbonate Sodium bicarbonate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Floxuridine Floxuridine The metabolism of Atazanavir can be decreased when combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Atazanavir.
Metaxalone Metaxalone Atazanavir may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Atazanavir.
Primidone Primidone The metabolism of Atazanavir can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Methsuximide.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Atazanavir.
Diazepam Diazepam The metabolism of Atazanavir can be decreased when combined with Diazepam.
Oxazepam Oxazepam Atazanavir may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Atazanavir may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Atazanavir may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam The metabolism of Lorazepam can be decreased when combined with Atazanavir.
Carmustine Carmustine Atazanavir may decrease the excretion rate of Carmustine which could result in a higher serum level.
Amantadine Amantadine Atazanavir may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Atazanavir may decrease the excretion rate of Codeine which could result in a higher serum level.
Bromocriptine Bromocriptine The metabolism of Atazanavir can be decreased when combined with Bromocriptine.
Tranylcypromine Tranylcypromine The metabolism of Atazanavir can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine Atazanavir may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Tetracycline Tetracycline The metabolism of Atazanavir can be decreased when combined with Tetracycline.
Minocycline Minocycline The serum concentration of Atazanavir can be decreased when it is combined with Minocycline.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Atazanavir.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Thioridazine.
Bleomycin Bleomycin Atazanavir may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Dapsone Dapsone The metabolism of Atazanavir can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The metabolism of Atazanavir can be decreased when combined with Sulfadiazine.
Methadone Methadone The metabolism of Atazanavir can be increased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Atazanavir can be decreased when combined with Oxybutynin.
Benztropine Benztropine Atazanavir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
Maprotiline Maprotiline Atazanavir may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Atazanavir.
Orphenadrine Orphenadrine The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Atazanavir.
Azathioprine Azathioprine Atazanavir may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Atazanavir.
Methylphenidate Methylphenidate Atazanavir may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Atazanavir.
Sulfasalazine Sulfasalazine The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Atazanavir.
Hydrocortisone Hydrocortisone The metabolism of Atazanavir can be decreased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Atazanavir can be decreased when combined with Doxorubicin.
Phenazopyridine Phenazopyridine The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Phenazopyridine.
Carbamazepine Carbamazepine The serum concentration of Carbamazepine can be decreased when it is combined with Atazanavir.
Methyldopa Methyldopa Atazanavir may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Atazanavir.
Hydralazine Hydralazine Atazanavir may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Atazanavir.
Clonazepam Clonazepam Atazanavir may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The metabolism of Atazanavir can be decreased when combined with Loperamide.
Promethazine Promethazine Promethazine can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Meclofenamate Meclofenamate Atazanavir may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Daunorubicin Daunorubicin Daunorubicin may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Atazanavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Atazanavir can be increased when combined with Griseofulvin.
Digoxin Digoxin Atazanavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine Atazanavir may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine Quinine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Atazanavir.
Calcitriol Calcitriol The metabolism of Atazanavir can be increased when combined with Calcitriol.
Triamterene Triamterene The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Atazanavir.
Sulfinpyrazone Sulfinpyrazone The metabolism of Atazanavir can be increased when combined with Sulfinpyrazone.
Metolazone Metolazone Atazanavir may decrease the excretion rate of Metolazone which could result in a higher serum level.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Atazanavir.
Secobarbital Secobarbital Atazanavir may decrease the excretion rate of Secobarbital which could result in a higher serum level.
Desipramine Desipramine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Desipramine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Atazanavir.
Imipramine Imipramine Atazanavir may decrease the excretion rate of Imipramine which could result in a higher serum level.
Probenecid Probenecid Atazanavir may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine The metabolism of Atazanavir can be decreased when combined with Quinidine.
Procainamide Procainamide Atazanavir may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Atazanavir may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Atazanavir may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Rifampin Rifampin The metabolism of Rifampicin can be increased when combined with Atazanavir.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Disopyramide.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Atazanavir.
Tamoxifen Tamoxifen The metabolism of Atazanavir can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital Atazanavir may decrease the excretion rate of Butabarbital which could result in a higher serum level.
Levothyroxine Levothyroxine The metabolism of Levothyroxine can be decreased when combined with Atazanavir.
Liothyronine Liothyronine Atazanavir may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole The metabolism of Atazanavir can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Atazanavir.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Atazanavir.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Atazanavir.
Dextromethorphan Dextromethorphan The metabolism of Atazanavir can be decreased when combined with Dextromethorphan.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Atazanavir.
Niacin Niacin The metabolism of Atazanavir can be decreased when combined with Niacin.
Baclofen Baclofen Atazanavir may decrease the excretion rate of Baclofen which could result in a higher serum level.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Atazanavir.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Atazanavir.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Atazanavir.
Ethambutol Ethambutol Atazanavir may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Atazanavir.
Chlorzoxazone Chlorzoxazone Atazanavir may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
Pyridoxine Pyridoxine Atazanavir may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
Folic Acid Folic Acid Atazanavir may decrease the excretion rate of Folic acid which could result in a higher serum level.
Danazol Danazol The metabolism of Atazanavir can be decreased when combined with Danazol.
Disulfiram Disulfiram The therapeutic efficacy of Disulfiram can be decreased when used in combination with Atazanavir.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Atazanavir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Minoxidil Minoxidil The metabolism of Minoxidil can be decreased when combined with Atazanavir.
Nortriptyline Nortriptyline The metabolism of Atazanavir can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone Spironolactone may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Amphotericin B Injection Amphotericin B Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Atazanavir.
Phytonadione Phytonadione Atazanavir may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Nadolol Nadolol Atazanavir may decrease the excretion rate of Nadolol which could result in a higher serum level.
Allopurinol Allopurinol Atazanavir may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Atazanavir.
Flavoxate Flavoxate Atazanavir may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Atazanavir.
Colchicine Colchicine The serum concentration of Colchicine can be increased when it is combined with Atazanavir.
Cefaclor Cefaclor Atazanavir may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cefadroxil Cefadroxil Atazanavir may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefazolin.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Atazanavir.
Cefoxitin Injection Cefoxitin Injection The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefoxitin.
Dacarbazine Dacarbazine Atazanavir may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Acetazolamide Acetazolamide The metabolism of Atazanavir can be decreased when combined with Acetazolamide.
Cefotaxime Injection Cefotaxime Injection The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Atazanavir.
Calcitonin Salmon Injection Calcitonin Salmon Injection Atazanavir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Atazanavir.
Ketoconazole Ketoconazole The metabolism of Atazanavir can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel Atazanavir may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Atazanavir.
Vincristine Injection Vincristine Injection The metabolism of Atazanavir can be decreased when combined with Vincristine.
Dipyridamole Dipyridamole Dipyridamole may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Vinblastine Vinblastine The metabolism of Atazanavir can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Atazanavir.
Colistimethate Injection Colistimethate Injection The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Colistimethate.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Atazanavir.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Atazanavir.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Thiothixene.
Aspirin Aspirin The metabolism of Acetylsalicylic acid can be decreased when combined with Atazanavir.
Salsalate Salsalate The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Salsalate.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Atazanavir.
Temazepam Temazepam Atazanavir may decrease the excretion rate of Temazepam which could result in a higher serum level.
Triazolam Triazolam Atazanavir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Atazanavir may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Atazanavir.
Propantheline Propantheline Atazanavir may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Atazanavir.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Atazanavir.
Nifedipine Nifedipine The metabolism of Atazanavir can be increased when combined with Nifedipine.
Timolol Timolol Atazanavir may decrease the excretion rate of Timolol which could result in a higher serum level.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Atazanavir.
Atenolol Atenolol Atenolol may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Pindolol Pindolol Atazanavir may decrease the excretion rate of Pindolol which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Atazanavir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Atazanavir may decrease the excretion rate of Diflunisal which could result in a higher serum level.
Piroxicam Piroxicam Atazanavir may decrease the excretion rate of Piroxicam which could result in a higher serum level.
Bumetanide Bumetanide Atazanavir may decrease the excretion rate of Bumetanide which could result in a higher serum level.
Etoposide Etoposide The metabolism of Atazanavir can be decreased when combined with Etoposide.
Glyburide Glyburide The metabolism of Atazanavir can be decreased when combined with Glyburide.
Glipizide Glipizide Atazanavir may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide Atazanavir may decrease the excretion rate of Indapamide which could result in a higher serum level.
Amoxicillin Amoxicillin Atazanavir may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Dicloxacillin Dicloxacillin The metabolism of Atazanavir can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Atazanavir can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Atazanavir may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Atazanavir may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Pentamidine.
Ceftriaxone Injection Ceftriaxone Injection Atazanavir may decrease the excretion rate of Ceftriaxone which could result in a higher serum level.
Labetalol Labetalol Atazanavir may decrease the excretion rate of Labetalol which could result in a higher serum level.
Auranofin Auranofin Atazanavir may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Leuprolide.
Gemfibrozil Gemfibrozil The metabolism of Atazanavir can be decreased when combined with Gemfibrozil.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Atazanavir.
Ceftazidime Injection Ceftazidime Injection Atazanavir may decrease the excretion rate of Ceftazidime which could result in a higher serum level.
Ketoprofen Ketoprofen The metabolism of Ketoprofen can be decreased when combined with Atazanavir.
Cefotetan Injection Cefotetan Injection Atazanavir may decrease the excretion rate of Cefotetan which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Atazanavir.
Enalapril Enalapril The excretion of Enalapril can be decreased when combined with Atazanavir.
Flurbiprofen Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Atazanavir.
Amiodarone Amiodarone The serum concentration of Amiodarone can be increased when it is combined with Atazanavir.
Aztreonam Injection Aztreonam Injection Atazanavir may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Atazanavir may decrease the excretion rate of Buspirone which could result in a higher serum level.
Lovastatin Lovastatin The serum concentration of Lovastatin can be increased when it is combined with Atazanavir.
Ciprofloxacin Ciprofloxacin Atazanavir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mesalamine Mesalamine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Atazanavir.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Atazanavir.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Atazanavir.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Nimodipine.
Clozapine Clozapine The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Clozapine.
Estazolam Estazolam Atazanavir may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Atazanavir.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Ofloxacin.
Didanosine Didanosine The serum concentration of Atazanavir can be decreased when it is combined with Didanosine.
Pentostatin Injection Pentostatin Injection Atazanavir may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Clarithromycin Clarithromycin The serum concentration of Clarithromycin can be increased when it is combined with Atazanavir.
Etodolac Etodolac Atazanavir may decrease the excretion rate of Etodolac which could result in a higher serum level.
Felodipine Felodipine The metabolism of Atazanavir can be decreased when combined with Felodipine.
Fosinopril Fosinopril Atazanavir may decrease the excretion rate of Fosinopril which could result in a higher serum level.
Nabumetone Nabumetone The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Atazanavir.
Pravastatin Pravastatin Atazanavir may decrease the excretion rate of Pravastatin which could result in a higher serum level.
Simvastatin Simvastatin The metabolism of Atazanavir can be decreased when combined with Simvastatin.
Amlodipine Amlodipine The metabolism of Amlodipine can be decreased when combined with Atazanavir.
Teniposide Injection Teniposide Injection The metabolism of Atazanavir can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Itraconazole can be decreased when combined with Atazanavir.
Lisinopril Lisinopril Atazanavir may decrease the excretion rate of Lisinopril which could result in a higher serum level.
Oxaprozin Oxaprozin Atazanavir may decrease the excretion rate of Oxaprozin which could result in a higher serum level.
Atovaquone Atovaquone The metabolism of Atazanavir can be decreased when combined with Atovaquone.
Rifabutin Rifabutin The serum concentration of 25-O-Desacetylrifabutin, an active metabolite of Rifabutin, can be increased when used in combination with Atazanavir.
Sotalol Sotalol The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Sotalol.
Bisoprolol Bisoprolol Atazanavir may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Atazanavir.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Atazanavir.
Isradipine Isradipine Isradipine may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Omeprazole Omeprazole Atazanavir can cause a decrease in the absorption of Omeprazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cisapride Cisapride The serum concentration of Cisapride can be increased when it is combined with Atazanavir.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Atazanavir.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Atazanavir.
Nizatidine Nizatidine Nizatidine can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Atazanavir.
Fluvoxamine Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Atazanavir.
Nefazodone Nefazodone The metabolism of Nefazodone can be decreased when combined with Atazanavir.
Lamotrigine Lamotrigine The serum concentration of Lamotrigine can be decreased when it is combined with Atazanavir.
Losartan Losartan The metabolism of Atazanavir can be decreased when combined with Losartan.
Valacyclovir Valacyclovir Atazanavir may decrease the excretion rate of Valaciclovir which could result in a higher serum level.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Atazanavir.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Atazanavir.
Carboplatin Injection Carboplatin Injection Atazanavir may decrease the excretion rate of Carboplatin which could result in a higher serum level.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Atazanavir.
Lansoprazole Lansoprazole The therapeutic efficacy of Atazanavir can be decreased when used in combination with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Atazanavir can be decreased when combined with Ifosfamide.
Nicardipine Nicardipine The metabolism of Atazanavir can be decreased when combined with Nicardipine.
Bupropion Bupropion Atazanavir may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Atazanavir.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Atazanavir.
Metformin Metformin The therapeutic efficacy of Metformin can be decreased when used in combination with Atazanavir.
Nisoldipine Nisoldipine Atazanavir may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
Lamivudine Lamivudine Atazanavir may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Atazanavir.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Atazanavir.
Anastrozole Anastrozole The metabolism of Anastrozole can be decreased when combined with Atazanavir.
Gemcitabine Injection Gemcitabine Injection Atazanavir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Indinavir Indinavir The risk or severity of hyperbilirubinemia can be increased when Atazanavir is combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Atazanavir can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Atazanavir can be decreased when combined with Docetaxel.
Cidofovir Injection Cidofovir Injection Atazanavir may decrease the excretion rate of Cidofovir which could result in a higher serum level.
Meropenem Injection Meropenem Injection Atazanavir may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Atazanavir.
Zafirlukast Zafirlukast The metabolism of Atazanavir can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Atazanavir may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Atazanavir.
Topiramate Topiramate The metabolism of Topiramate can be increased when combined with Atazanavir.
Zileuton Zileuton The metabolism of Atazanavir can be decreased when combined with Zileuton.
Valsartan Valsartan The metabolism of Atazanavir can be decreased when combined with Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Atazanavir.
Pramipexole Pramipexole Atazanavir may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Atazanavir.
Nelfinavir Nelfinavir The metabolism of Atazanavir can be decreased when combined with Nelfinavir.
Fexofenadine Fexofenadine The excretion of Fexofenadine can be decreased when combined with Atazanavir.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Atazanavir.
Loratadine Loratadine Loratadine may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Atazanavir.
Nilutamide Nilutamide The metabolism of Atazanavir can be decreased when combined with Nilutamide.
Flutamide Flutamide Atazanavir may decrease the excretion rate of Flutamide which could result in a higher serum level.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Atazanavir.
Bicalutamide Bicalutamide The metabolism of Atazanavir can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Atazanavir.
Propafenone Propafenone The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Propafenone.
Raloxifene Raloxifene The metabolism of Raloxifene can be decreased when combined with Atazanavir.
Irbesartan Irbesartan The metabolism of Atazanavir can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin Atazanavir may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Quetiapine Quetiapine The serum concentration of Quetiapine can be increased when it is combined with Atazanavir.
Cefepime Injection Cefepime Injection The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefepime.
Cefprozil Cefprozil The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefprozil.
Cefpodoxime Cefpodoxime The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefpodoxime.
Cetirizine Cetirizine Atazanavir may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Paroxetine Paroxetine The metabolism of Atazanavir can be decreased when combined with Paroxetine.
Tolcapone Tolcapone The metabolism of Atazanavir can be decreased when combined with Tolcapone.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Citalopram.
Capecitabine Capecitabine The metabolism of Atazanavir can be decreased when combined with Capecitabine.
Efavirenz Efavirenz The serum concentration of Atazanavir can be decreased when it is combined with Efavirenz.
Abacavir Abacavir The serum concentration of Abacavir can be decreased when it is combined with Atazanavir.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Atazanavir.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Atazanavir.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Atazanavir.
Rosiglitazone Rosiglitazone Atazanavir may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Tolterodine Tolterodine The serum concentration of Tolterodine can be increased when it is combined with Atazanavir.
Thalidomide Thalidomide The metabolism of Atazanavir can be decreased when combined with Thalidomide.
Oseltamivir Oseltamivir Atazanavir may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Aluminum Hydroxide Aluminum Hydroxide Aluminum hydroxide can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Atazanavir.
Nateglinide Nateglinide Atazanavir may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Atazanavir.
Rabeprazole Rabeprazole Atazanavir can cause a decrease in the absorption of Rabeprazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Terbinafine Terbinafine The metabolism of Atazanavir can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists